The Role and Advancements in the Platelet Aggregation Devices Market for Hemostasis and Thrombosis Management
The Platelet Aggregation Devices Market plays a vital role in hemostasis and thrombosis management, with its growth primarily fueled by the rising prevalence of cardiovascular diseases (CVDs) and ongoing advancements in diagnostic technologies. Platelets are crucial for primary hemostasis—the initial formation of a plug at a site of injury—and provide a catalytic surface for the activation of the coagulation cascade (secondary hemostasis). Platelet aggregation devices, or aggregometers, are essential diagnostic tools used to monitor platelet function ex vivo, typically in platelet-rich plasma or whole blood, by measuring the kinetics and maximal aggregation response to various agonists like ADP or collagen. This capability is critical for identifying platelet function abnormalities, assessing a patient's risk of bleeding or thrombosis, and, most importantly, monitoring the effectiveness of antiplatelet therapies, such as aspirin and P2Y12 inhibitors, in patients with…